CellaVision AB (OSTO:CEVI) Cyclically Adjusted FCF per Share: kr0.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:CEVI CellaVision AB OSTO:CEVI
95 GF Score
Price kr147.20
GF Value kr211.14
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is CellaVision AB Cyclically Adjusted FCF per Share?

CellaVision AB OSTO:CEVI +7.76% 95 Cyclically Adjusted FCF per Share is kr0.00 as of Jun. 2026. GuruFocus rates OSTO:CEVI with a GF Score™ of 95/100 and a GF Value™ of kr211.14 (Significantly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

CellaVision AB's adjusted free cash flow per share for the three months ended in Jun. 2026 was kr0.473. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is kr0.00 for the trailing ten years ended in Jun. 2026.

During the past 12 months, CellaVision AB's average Cyclically Adjusted FCF Growth Rate was 6.40% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 9.80% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 14.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of CellaVision AB was 18.70% per year. The lowest was 9.80% per year. And the median was 15.70% per year.

As of today (2026-07-20), CellaVision AB's current stock price is kr147.20. CellaVision AB's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was kr0.00. CellaVision AB's Cyclically Adjusted Price-to-FCF of today is .

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of CellaVision AB was 227.55. The lowest was 29.82. And the median was 122.96.


CellaVision AB  (OSTO:CEVI) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of CellaVision AB was 227.55. The lowest was 29.82. And the median was 122.96.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


CellaVision AB Cyclically Adjusted FCF per Share Related Terms


CellaVision AB Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for CellaVision AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CellaVision AB Cyclically Adjusted FCF per Share Chart

CellaVision AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.31 2.90 3.41 3.79 3.84

CellaVision AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.91 3.76 3.84 3.97 0.00

OSTO:CEVI vs ABT, SYK, MDT: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, CellaVision AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellaVision AB Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CellaVision AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where CellaVision AB's Cyclically Adjusted Price-to-FCF falls into.


OSTO:CEVI
95GF Score
CellaVision AB OSTO:CEVI
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CellaVision AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CellaVision AB's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.473/134.1100*134.1100
=0.473

Current CPI (Jun. 2026) = 134.1100.

CellaVision AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 0.279 101.138 0.370
201612 1.113 102.022 1.463
201703 0.732 102.022 0.962
201706 0.561 102.752 0.732
201709 0.295 103.279 0.383
201712 0.878 103.793 1.134
201803 -0.016 103.962 -0.021
201806 1.010 104.875 1.292
201809 0.956 105.679 1.213
201812 0.196 105.912 0.248
201903 1.948 105.886 2.467
201906 0.568 106.742 0.714
201909 1.219 107.214 1.525
201912 0.764 107.766 0.951
202003 0.307 106.563 0.386
202006 1.056 107.498 1.317
202009 -0.441 107.635 -0.549
202012 0.644 108.296 0.798
202103 0.574 108.360 0.710
202106 -0.217 108.928 -0.267
202109 1.611 110.338 1.958
202112 1.193 112.486 1.422
202203 1.053 114.825 1.230
202206 0.905 118.384 1.025
202209 0.755 122.296 0.828
202212 0.131 126.365 0.139
202303 -0.186 127.042 -0.196
202306 0.280 129.407 0.290
202309 2.295 130.224 2.363
202312 2.221 131.912 2.258
202403 2.266 132.205 2.299
202406 0.880 132.716 0.889
202409 1.023 132.304 1.037
202412 0.875 132.987 0.882
202503 1.679 132.825 1.695
202506 1.393 133.699 1.397
202509 0.311 133.480 0.312
202512 1.407 133.390 1.415
202603 1.925 133.560 1.933
202606 0.473 134.110 0.473

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of kr0.00 mean?
CellaVision AB (OSTO:CEVI) has a Cyclically Adjusted FCF per Share of kr0.00 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on CellaVision AB and its competitors.
Is CellaVision AB's Cyclically Adjusted FCF per Share too high?
CellaVision AB's current Cyclically Adjusted FCF per Share is kr0.00. Overall, CellaVision AB has a GF Score™ of 95/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CellaVision AB's Cyclically Adjusted FCF per Share compare to ABT and SYK?
CellaVision AB's Cyclically Adjusted FCF per Share of kr0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on CellaVision AB and its competitors. CellaVision AB's current Cyclically Adjusted FCF per Share is kr0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CellaVision AB stock overvalued right now?
Based on GuruFocus' analysis, CellaVision AB (OSTO:CEVI) is currently considered Significantly Undervalued. The stock's GF Value™ is kr211.14, compared to a current price of kr147.20 — trading 30.3% below its estimated fair value. The current Cyclically Adjusted FCF per Share is kr0.00. CellaVision AB's overall GF Score™ is 95/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For CellaVision AB (OSTO:CEVI), the current Cyclically Adjusted FCF per Share is kr0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CellaVision AB (OSTO:CEVI) Overvalued in 2026?

Based on GuruFocus' analysis, CellaVision AB stock appears to be undervalued. The current stock price of kr147.20 is trading 30.3% below its estimated GF Value™ of kr211.14. GuruFocus considers CellaVision AB to be Significantly Undervalued.

Key valuation signals for OSTO:CEVI:

  • Cyclically Adjusted FCF per Share: kr0.00
  • GF Value™: kr211.14 vs. price of kr147.20 (30.3% below fair value)
  • GF Score™: 95/100 with 1 warning sign

No single metric tells the full story. See the OSTO:CEVI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CellaVision AB Business Description

Address Mobilvagen 12, Lund, SWE, 22362
CellaVision AB is engaged in developing and selling instruments, software, and reagents for blood and body fluid analysis. The company automates parts of the sample preparation process and replaces manual microscopes with instruments based on digital image analysis technology and artificial intelligence. The solutions contribute to more effective workflows and higher quality in laboratory medicine. The product offer consists of products and solutions for standardized laboratory diagnostics and improved performance for cellular image processing and systems for digital microscopy in hematology, consisting of reagents, instruments, and supplementary software and peripheral equipment.
95GF Score

Get the complete analysis for OSTO:CEVI

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr147.20
Price
kr211.14
GF Value